PD-L1 Expression in Lung Cancer
Phase 2
Recruiting
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Diagnostic Test: [99mTc]-NM01 SPECT/CT
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- NanoMab Technology (UK) Limited
- Target Recruit Count
- 15
- Registration Number
- NCT04992715
- Locations
- 🇬🇧
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath